Evexia Lifecare Submits SEBI Depositories Compliance Certificate for Q4 FY26

1 min read     Updated on 07 Apr 2026, 10:36 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Evexia Lifecare Limited filed its quarterly confirmation certificate under SEBI (Depositories and Participants) Regulations for the quarter ended March 31, 2026. The certificate from RTA MUFG Intime India Private Limited confirms proper processing of securities dematerialization and compliance with regulatory timelines.

powered bylight_fuzz_icon
37037598

*this image is generated using AI for illustrative purposes only.

Evexia Lifecare Limited has submitted its quarterly confirmation certificate to the Bombay Stock Exchange (BSE) under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The certificate was filed on April 07, 2026, by Chairman and Managing Director Jayeshbhai Raichandbhai Thakkar.

SEBI Depositories Compliance Certificate

The company filed the required confirmation certificate received from MUFG Intime India Private Limited (formerly Link Intime India Private Limited), serving as the company's Registrar and Share Transfer Agent (RTA). This regulatory filing ensures compliance with depositories regulations regarding securities dematerialization and rematerialization processes during the quarter.

Filing Details: Information
Regulation: SEBI (Depositories and Participants) Regulations, 2018
Specific Provision: Regulation 74(5)
Quarter Covered: March 31, 2026
Filing Date: April 07, 2026
Scrip Code: 524444
Scrip Symbol: EVEXIA

RTA Confirmation Certificate

MUFG Intime India Private Limited issued the confirmation certificate on April 03, 2026, confirming that all securities received from depository participants for dematerialization during the quarter ended March 31, 2026, were properly processed. The RTA confirmed that securities were accepted or rejected to the depositories within prescribed timelines and that all security certificates received were mutilated and cancelled after due verification.

RTA Details: Information
Company Name: MUFG Intime India Private Limited
Former Name: Link Intime India Private Limited
CIN: U67190MH1999PTC118368
Certificate Date: April 03, 2026
Authorized Signatory: Ashok Shetty, Sr. Vice President

Corporate Governance and Compliance

The filing demonstrates Evexia Lifecare's commitment to maintaining regulatory compliance with SEBI depositories regulations. The RTA confirmed that the names of depositories have been substituted in the register of members as registered owners within prescribed timelines, ensuring proper maintenance of shareholding records.

This quarterly compliance certificate is part of SEBI's framework to monitor depositories and participants' operations, ensuring transparency in securities dematerialization processes. The comprehensive disclosure provides regulatory authorities with confirmation of proper handling of securities transactions during the quarter, maintaining investor confidence in the company's compliance standards.

Historical Stock Returns for Evexia Lifecar

1 Day5 Days1 Month6 Months1 Year5 Years
+3.64%+11.76%-61.74%-71.78%-77.99%-95.94%

How might MUFG Intime India's rebranding from Link Intime affect Evexia Lifecare's future share transfer operations and costs?

What impact could increased SEBI scrutiny on depositories compliance have on Evexia Lifecare's operational expenses in upcoming quarters?

Will Evexia Lifecare consider switching to alternative RTAs if MUFG Intime's service quality or pricing changes post-rebranding?

Evexia Lifecare Limited Reports Strong Q3FY26 Results with 111.8% Profit Growth

2 min read     Updated on 17 Feb 2026, 06:12 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Evexia Lifecare Limited delivered impressive Q3FY26 performance with standalone net profit surging 111.8% to ₹40.73 lakhs and revenue from operations growing 14.0% to ₹2,459.92 lakhs. The consolidated results showed even stronger growth with net profit jumping 148.4% to ₹29.19 lakhs, reflecting the company's operational efficiency and disciplined expense management across its seven subsidiaries.

powered bylight_fuzz_icon
32877508

*this image is generated using AI for illustrative purposes only.

Evexia Lifecare Limited has delivered impressive financial performance for the third quarter of FY2026, with the Board of Directors approving unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025. The results were approved during a board meeting held on February 17, 2026, which was adjourned from February 14, 2026.

Strong Quarterly Performance

The company demonstrated robust growth in its standalone operations during Q3FY26. Net profit surged significantly compared to the previous year, while revenue from operations showed healthy expansion despite some sequential moderation.

Metric: Q3FY26 Q3FY25 YoY Growth
Revenue from Operations: ₹2,459.92 lakhs ₹2,157.97 lakhs +14.0%
Total Revenue: ₹2,485.88 lakhs ₹2,167.97 lakhs +14.7%
Net Profit: ₹40.73 lakhs ₹19.23 lakhs +111.8%
Basic EPS: ₹0.002 ₹0.001 +100.0%

Nine-Month Performance Highlights

For the nine-month period from April 1, 2025 to December 31, 2025, the company maintained its growth trajectory across key financial parameters.

Parameter: 9M FY26 9M FY25 Growth
Revenue from Operations: ₹7,028.54 lakhs ₹6,870.76 lakhs +2.3%
Total Revenue: ₹7,088.43 lakhs ₹6,881.00 lakhs +3.0%
Net Profit: ₹131.58 lakhs ₹117.80 lakhs +11.7%
Basic EPS: ₹0.007 ₹0.006 +16.7%

Consolidated Results Overview

The consolidated financial results also reflected positive performance, incorporating results from seven subsidiaries across India, UK, and Tongo. The consolidated net profit for Q3FY26 stood at ₹29.19 lakhs compared to ₹11.75 lakhs in Q3FY25, representing substantial year-on-year growth.

Consolidated Metrics: Q3FY26 Q3FY25 Change
Revenue from Operations: ₹2,524.38 lakhs ₹2,169.97 lakhs +16.3%
Net Profit: ₹29.19 lakhs ₹11.75 lakhs +148.4%

Operational Efficiency

The company's expense management remained disciplined during the quarter. Total expenses for Q3FY26 standalone operations were ₹2,430.84 lakhs compared to ₹2,141.98 lakhs in the previous year. The profit before tax increased to ₹55.04 lakhs from ₹25.99 lakhs, demonstrating improved operational efficiency.

Board Meeting and Regulatory Compliance

The board meeting commenced at 04:00 p.m. and concluded at 05:30 p.m. on February 17, 2026. The meeting was presided over by Chairman & Managing Director Jitesh Raichandbhai Thakkar (DIN: 01631093). The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and have undergone limited review by statutory auditors Tejas K. Soni and Company, Chartered Accountants. The results comply with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The company maintains a paid-up equity share capital of ₹18,773.28 lakhs with a face value of ₹1 per share.

Historical Stock Returns for Evexia Lifecar

1 Day5 Days1 Month6 Months1 Year5 Years
+3.64%+11.76%-61.74%-71.78%-77.99%-95.94%

More News on Evexia Lifecar

1 Year Returns:-77.99%